Back to Search
Start Over
Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030
- Source :
- M2 Presswire. May 11, 2020
- Publication Year :
- 2020
-
Abstract
- M2 PRESSWIRE-May 11, 2020-: Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:11052020 The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast [...]
- Subjects :
- Merck KGaA -- Forecasts and trends
Takeda Pharmaceutical Company Ltd. -- Forecasts and trends
Novartis Pharma AG -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Eli Lilly and Co. -- Forecasts and trends
Brigatinib -- Forecasts and trends -- Reports
Osimertinib -- Forecasts and trends -- Reports
Monoclonal antibodies -- Reports -- Forecasts and trends
Trametinib -- Reports -- Forecasts and trends
Romiplostim -- Reports -- Forecasts and trends
Pembrolizumab -- Forecasts and trends -- Reports
Epidemiology -- Reports -- Forecasts and trends
Non-small cell lung cancer -- Reports -- Forecasts and trends
Alectinib -- Forecasts and trends -- Reports
Durvalumab -- Reports -- Forecasts and trends
Dabrafenib -- Reports -- Forecasts and trends
Nivolumab -- Reports -- Forecasts and trends
Small cell lung cancer -- Forecasts and trends -- Reports
Pharmaceutical industry -- Forecasts and trends
Avelumab
Necitumumab
Larotrectinib
Atezolizumab
Dacomitinib
Lorlatinib
Lung cancer
Profits
Market trend/market analysis
Business
Business, international
Opdivo (Medication) -- Reports
Keytruda (Medication) -- Reports
Tagrisso (Medication) -- Reports
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.623433427